We had some good news late on Friday:

Fluence signs agreement with existing China customer for anticipated Aspiral™ sales
estimated at minimum US$45M over three years
Aspiral™ units will treat wastewater along the highway system in central China
Approximately 80 plants are expected to be delivered during the coming 18 months

https://stocknessmonster.com/announc....asx-3A503065/

discl. hold